Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORTHOPEDIATRICS CORP Director's Dealing 2020

May 21, 2020

32906_dirs_2020-05-21_9cbf4a0f-455f-4d74-942e-ce759b1f3077.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2020-05-20

Reporting Person: Throdahl Mark C (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-20 Common Stock M 670 $30.97 Acquired 155616 Direct
2020-05-20 Common Stock M 402 $30.97 Acquired 156018 Direct
2020-05-20 Common Stock M 402 $30.97 Acquired 156420 Direct
2020-05-20 Common Stock M 402 $30.97 Acquired 156822 Direct
2020-05-20 Common Stock S 670 $46.56 Disposed 156152 Direct
2020-05-20 Common Stock S 402 $46.56 Disposed 155750 Direct
2020-05-20 Common Stock S 402 $46.56 Disposed 155348 Direct
2020-05-20 Common Stock S 402 $46.57 Disposed 154946 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-20 Stock Option (Right to Buy) $30.97 M 670 Disposed 2020-09-02 Common Stock (670.0) Direct
2020-05-20 Stock Option (Right to Buy) $30.97 M 402 Disposed 2021-08-03 Common Stock (402.0) Direct
2020-05-20 Stock Option (Right to Buy) $30.97 M 402 Disposed 2022-08-23 Common Stock (402.0) Direct
2020-05-20 Stock Option (Right to Buy) $30.97 M 402 Disposed 2023-09-10 Common Stock (402.0) Direct

Footnotes

F1: The stock option is fully vested and immediately exercisable.